M Mamoulaki Selected Research

Cyclosporine (Ciclosporin)

4/2006

An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Mamoulaki Research Topics

Disease

3	Rheumatoid Arthritis 01/2007 - 07/2005
1	Systemic Scleroderma (Systemic Sclerosis) 01/2007
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2007
1	Vascular Diseases (Vascular Disease) 01/2007
1	Ankylosing Spondylitis 07/2005
1	Psoriatic Arthritis 07/2005
1	Infections 07/2005
1	Spondylarthropathies 07/2005
1	Hypersensitivity (Allergy) 07/2005

Drug/Important Bio-Agent (IBA)

3	Infliximab (Remicade)FDA Link 01/2007 - 07/2005
1	CollagenIBA 01/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2006
1	Methotrexate (Mexate)FDA LinkGeneric 04/2006

Therapy/Procedure

2	Therapeutics 01/2007 - 07/2005